Granules India gets USFDA approval for potassium chloride tablets
NEW DELHI: Drug firm Granules India on Thursday said it has received marketing approval from the US health regulator for Potassium Chloride extended release tablets, used for treatment of patients with hypokalemia. Hypokalemia is a condition when the potassium level in a patient’s blood is too low. The approved product is bioequivalent to the reference […]